Loading...
Mechanisms of failure of chimeric antigen receptor T-cell therapy
Although chimeric antigen receptor T (CART)-cell therapy is best recognized for its antitumor effect in relapsed/refractory B-cell hematological cancers, it is still associated with a high relapse rate. RECENT FINDINGS: We firstly analyzed internal immunological and genetic reasons of CD19+ relapse...
Saved in:
| Published in: | Curr Opin Hematol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Lippincott Williams And Wilkins
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791516/ https://ncbi.nlm.nih.gov/pubmed/31577606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0000000000000548 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|